MOESM4 of Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials

MLA

Da-Ya Yang, et al. MOESM4 of Comparative Outcomes of Heart Failure among Existent Classes of Anti-Diabetic Agents: A Network Meta-Analysis of 171,253 Participants from 91 Randomized Controlled Trials. Jan. 2019. EBSCOhost, https://doi.org/10.6084/m9.figshare.7967672.

APA

Da-Ya Yang, He, X., Liang, H.-W., Shao-Zhao Zhang, Zhong, X.-B., Chu-Fan Luo, Du, Z.-M., Jian-Gui He, Zhuang, X.-D., & Xin-Xue Liao. (2019). MOESM4 of Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials. https://doi.org/10.6084/m9.figshare.7967672

Chicago

Da-Ya Yang, Xin He, Hui-Wei Liang, Shao-Zhao Zhang, Xiang-Bin Zhong, Chu-Fan Luo, Zhi-Min Du, Jian-Gui He, Xiao-Dong Zhuang, and Xin-Xue Liao. 2019. “MOESM4 of Comparative Outcomes of Heart Failure among Existent Classes of Anti-Diabetic Agents: A Network Meta-Analysis of 171,253 Participants from 91 Randomized Controlled Trials,” January. doi:10.6084/m9.figshare.7967672.